US Stock MarketDetailed Quotes

SNTI Senti Biosciences

Watchlist
  • 3.4300
  • +0.1043+3.14%
Close Mar 28 16:00 ET
  • 3.4300
  • 0.00000.00%
Post 20:01 ET
89.19MMarket Cap-0.29P/E (TTM)

Senti Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
-39.81%1.98M
0
-83.18%255K
-38.00%687K
21.31%1.04M
Operating revenue
--0
--0
--0
--0
--0
-39.81%1.98M
--0
-83.18%255K
-38.00%687K
21.31%1.04M
Cost of revenue
Gross profit
Operating expense
-11.66%60.73M
-12.26%16.17M
-19.19%14.9M
-15.87%13.36M
1.88%16.3M
5.16%68.74M
10.99%18.43M
13.38%18.44M
-30.61%15.88M
26.86%16M
Selling and administrative expenses
-32.57%23.51M
-10.36%7.69M
-34.42%5.53M
-60.55%3.49M
-24.54%6.8M
-7.35%34.87M
-6.99%8.58M
-15.59%8.44M
-36.30%8.84M
71.31%9.01M
-General and administrative expense
-32.57%23.51M
-10.36%7.69M
-34.42%5.53M
-60.55%3.49M
-24.54%6.8M
-7.35%34.87M
-6.99%8.58M
-15.59%8.44M
-36.30%8.84M
71.31%9.01M
Research and development costs
6.86%34.36M
-14.80%7.77M
-4.81%8.66M
33.09%9.15M
24.37%8.78M
14.23%32.15M
29.63%9.12M
39.47%9.09M
-25.64%6.88M
-7.16%7.06M
Depreciation amortization depletion
23.92%2.86M
-2.89%705K
-28.17%714K
76.35%716K
297.80%724K
289.86%2.31M
--726K
--994K
--406K
--182K
-Depreciation and amortization
23.92%2.86M
-2.89%705K
-28.17%714K
76.35%716K
297.80%724K
289.86%2.31M
--726K
--994K
--406K
--182K
Other operating expenses
----
----
----
----
----
41.70%-583K
--0
66.80%-83K
0.00%-250K
0.00%-250K
Operating profit
9.05%-60.73M
12.26%-16.17M
18.05%-14.9M
12.06%-13.36M
-8.93%-16.3M
-7.54%-66.77M
-9.72%-18.43M
-23.30%-18.19M
30.24%-15.19M
-27.27%-14.96M
Net non-operating interest income expense
-66.90%948K
-46.01%230K
-74.27%150K
-70.28%236K
-68.80%331K
68.37%2.86M
-62.23%426K
7.56%583K
2,840.74%794K
26,425.00%1.06M
Non-operating interest income
-66.90%948K
-46.01%230K
-74.27%150K
-70.28%236K
-68.80%331K
68.37%2.86M
-62.23%426K
7.56%583K
2,840.74%794K
26,425.00%1.06M
Other net income (expense)
135.83%6.99M
2,331.00%15.33M
25.77%-14.11M
1,231.25%1.92M
7,466.67%3.86M
-281.98%-19.51M
-201.33%-687K
-19,501.03%-19.01M
-98.59%144K
194.44%51K
Gain on sale of security
-421.34%-12.73M
--0
-366.65%-15.45M
--324K
--2.4M
--3.96M
---1.83M
--5.79M
----
----
Special income (charges)
98.86%-293K
107.38%20K
98.78%-313K
--0
--0
-339.58%-25.76M
-139.74%-271K
-25,850.51%-25.69M
-98.54%148K
--59K
-Less：Restructuring and merger&acquisition
90.34%-20K
---20K
--0
--0
--0
97.81%-207K
--0
--0
98.33%-148K
---59K
-Less:Impairment of capital assets
-98.79%313K
--0
-98.78%313K
----
----
--25.96M
--271K
--25.69M
----
----
Other non- operating income (expenses)
773.62%20.01M
980.24%15.31M
85.99%1.65M
39,925.00%1.59M
18,362.50%1.46M
7,256.25%2.29M
35,525.00%1.42M
44,150.00%885K
-116.00%-4K
85.19%-8K
Income before tax
36.71%-52.79M
96.74%-610K
21.16%-28.87M
21.38%-11.2M
12.57%-12.11M
-67.94%-83.41M
-24.69%-18.69M
-156.00%-36.62M
-23.36%-14.25M
-17.31%-13.85M
Income tax
Net income
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
-22.07%-71.06M
-2.78%-18.72M
10.32%-14.92M
-61.85%-18.7M
-58.55%-18.72M
Net income continuous Operations
36.71%-52.79M
96.74%-610K
21.16%-28.87M
21.38%-11.2M
12.57%-12.11M
-67.94%-83.41M
-24.69%-18.69M
-156.00%-36.62M
-23.36%-14.25M
-17.31%-13.85M
Net income discontinuous operations
--0
--0
--0
--0
--0
244.51%12.35M
99.13%-28K
1,028.20%21.69M
---4.45M
---4.87M
Minority interest income
Net income attributable to the parent company
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
-22.07%-71.06M
-2.78%-18.72M
10.32%-14.92M
-61.85%-18.7M
-58.55%-18.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
-22.07%-71.06M
-2.78%-18.72M
10.32%-14.92M
-61.85%-18.7M
-58.55%-18.72M
Basic earnings per share
24.86%-12.03
84.01%-0.67
-87.80%-6.31
41.94%-2.45
38.10%-2.6
28.21%-16.01
0.24%-4.19
11.58%-3.36
50.93%-4.22
-55.28%-4.2
Diluted earnings per share
24.86%-12.03
84.01%-0.67
-87.80%-6.31
41.94%-2.45
38.10%-2.6
28.21%-16.01
0.24%-4.19
11.58%-3.36
50.93%-4.22
-55.28%-4.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 00000-39.81%1.98M0-83.18%255K-38.00%687K21.31%1.04M
Operating revenue --0--0--0--0--0-39.81%1.98M--0-83.18%255K-38.00%687K21.31%1.04M
Cost of revenue
Gross profit
Operating expense -11.66%60.73M-12.26%16.17M-19.19%14.9M-15.87%13.36M1.88%16.3M5.16%68.74M10.99%18.43M13.38%18.44M-30.61%15.88M26.86%16M
Selling and administrative expenses -32.57%23.51M-10.36%7.69M-34.42%5.53M-60.55%3.49M-24.54%6.8M-7.35%34.87M-6.99%8.58M-15.59%8.44M-36.30%8.84M71.31%9.01M
-General and administrative expense -32.57%23.51M-10.36%7.69M-34.42%5.53M-60.55%3.49M-24.54%6.8M-7.35%34.87M-6.99%8.58M-15.59%8.44M-36.30%8.84M71.31%9.01M
Research and development costs 6.86%34.36M-14.80%7.77M-4.81%8.66M33.09%9.15M24.37%8.78M14.23%32.15M29.63%9.12M39.47%9.09M-25.64%6.88M-7.16%7.06M
Depreciation amortization depletion 23.92%2.86M-2.89%705K-28.17%714K76.35%716K297.80%724K289.86%2.31M--726K--994K--406K--182K
-Depreciation and amortization 23.92%2.86M-2.89%705K-28.17%714K76.35%716K297.80%724K289.86%2.31M--726K--994K--406K--182K
Other operating expenses --------------------41.70%-583K--066.80%-83K0.00%-250K0.00%-250K
Operating profit 9.05%-60.73M12.26%-16.17M18.05%-14.9M12.06%-13.36M-8.93%-16.3M-7.54%-66.77M-9.72%-18.43M-23.30%-18.19M30.24%-15.19M-27.27%-14.96M
Net non-operating interest income expense -66.90%948K-46.01%230K-74.27%150K-70.28%236K-68.80%331K68.37%2.86M-62.23%426K7.56%583K2,840.74%794K26,425.00%1.06M
Non-operating interest income -66.90%948K-46.01%230K-74.27%150K-70.28%236K-68.80%331K68.37%2.86M-62.23%426K7.56%583K2,840.74%794K26,425.00%1.06M
Other net income (expense) 135.83%6.99M2,331.00%15.33M25.77%-14.11M1,231.25%1.92M7,466.67%3.86M-281.98%-19.51M-201.33%-687K-19,501.03%-19.01M-98.59%144K194.44%51K
Gain on sale of security -421.34%-12.73M--0-366.65%-15.45M--324K--2.4M--3.96M---1.83M--5.79M--------
Special income (charges) 98.86%-293K107.38%20K98.78%-313K--0--0-339.58%-25.76M-139.74%-271K-25,850.51%-25.69M-98.54%148K--59K
-Less：Restructuring and merger&acquisition 90.34%-20K---20K--0--0--097.81%-207K--0--098.33%-148K---59K
-Less:Impairment of capital assets -98.79%313K--0-98.78%313K----------25.96M--271K--25.69M--------
Other non- operating income (expenses) 773.62%20.01M980.24%15.31M85.99%1.65M39,925.00%1.59M18,362.50%1.46M7,256.25%2.29M35,525.00%1.42M44,150.00%885K-116.00%-4K85.19%-8K
Income before tax 36.71%-52.79M96.74%-610K21.16%-28.87M21.38%-11.2M12.57%-12.11M-67.94%-83.41M-24.69%-18.69M-156.00%-36.62M-23.36%-14.25M-17.31%-13.85M
Income tax
Net income 25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M-22.07%-71.06M-2.78%-18.72M10.32%-14.92M-61.85%-18.7M-58.55%-18.72M
Net income continuous Operations 36.71%-52.79M96.74%-610K21.16%-28.87M21.38%-11.2M12.57%-12.11M-67.94%-83.41M-24.69%-18.69M-156.00%-36.62M-23.36%-14.25M-17.31%-13.85M
Net income discontinuous operations --0--0--0--0--0244.51%12.35M99.13%-28K1,028.20%21.69M---4.45M---4.87M
Minority interest income
Net income attributable to the parent company 25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M-22.07%-71.06M-2.78%-18.72M10.32%-14.92M-61.85%-18.7M-58.55%-18.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M-22.07%-71.06M-2.78%-18.72M10.32%-14.92M-61.85%-18.7M-58.55%-18.72M
Basic earnings per share 24.86%-12.0384.01%-0.67-87.80%-6.3141.94%-2.4538.10%-2.628.21%-16.010.24%-4.1911.58%-3.3650.93%-4.22-55.28%-4.2
Diluted earnings per share 24.86%-12.0384.01%-0.67-87.80%-6.3141.94%-2.4538.10%-2.628.21%-16.010.24%-4.1911.58%-3.3650.93%-4.22-55.28%-4.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Shenzhen Kaifa Technology
920029
+150.36%
Shanghai Yongli Belting
300230
+20.04%
Guomai Culture & Media
301052
+20.00%
4
WuHan Hvsen Biotechnology
300871
+19.05%
5
CHANGFU CO.,LTD
871396
+18.10%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.